| 摘要 |
A glucagon-like peptide-1 (GLP-1) peptide analogue of the formula (Aib8,35)hGLP-1(7-36)NH2 and pharmaceutical compositions comprising the compound of this formula. The compound is suitable for use in the treatment of type I diabetes, type II diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, retinosis and neurodegenerative disease.
|
